Skip to main content
Premium Trial:

Request an Annual Quote

Qlucore, Filgen Ink Distribution Deal for Japan

NEW YORK (GenomeWeb News) – Swedish bioinformatics firm Qlucore announced on Monday a deal with Filgen to distribute Qlucore's Omics Explorer software in Japan.

Financial and other terms of the deal were not disclosed.

Omics Explorer is a software program that enables analysis of data sets from gene expression, DNA methylation, and protein expression research, as well as other fields of study. The product uses dynamic principal component analysis, which projects high dimensional data to lower dimensions. The specific projections of the data are chosen to maintain variance in the projected dataset. Data is then projected and plotted on a computer screen and rotated manually or automatically.

According to Qlucore, its deal with Filgen will provide researchers in Japan with a data analysis tool that is "powerful and yet easy to use … [that] will be invaluable for unveiling important new discoveries."

"Japan currently represents the third-largest biotech market in the world after the US and the [European Union], so this is clearly a very important opportunity for us," Qlucore President Carl-Johan Ivarsson said in a statement.

Based in Nagoya, Japan, Filgen develops, manufactures, and sells science research equipment and provides analysis services to the life sciences market.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.